ATHA - Athira Pharma, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Bothell,
United States
ATHA price evolution
ATHA
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.02 | $110.54 | $107.33 | $131.7 |
| Short term investments | $145.72 | $143.22 | $128.45 | $153.24 |
| Net receivables | $2.23 | $2.34 | $2.08 | $2.59 |
| Inventory | ||||
| Total current assets | $269.15 | $260.8 | $238.99 | $290.5 |
| Long term investments | $37.64 | $65.94 | $103.65 | $64.94 |
| Property, plant & equipment | $5.77 | $5.22 | $4.57 | $4.46 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $43.85 | $71.21 | $108.34 | $69.63 |
| Total investments | $183.36 | $209.16 | $232.1 | $218.18 |
| Total assets | $313 | $332.01 | $347.33 | $360.12 |
| Current liabilities | ||||
| Accounts payable | $1.43 | $0.57 | $0.96 | $1.17 |
| Deferred revenue | ||||
| Short long term debt | $0.3 | $0.29 | $0.28 | $0.26 |
| Total current liabilities | $9.47 | $9.29 | $9.39 | $7.63 |
| Long term debt | $1.55 | $1.63 | $1.71 | $1.78 |
| Total noncurrent liabilities | $1.55 | $1.63 | $1.71 | $1.78 |
| Total debt | $1.85 | $1.92 | $1.99 | $2.04 |
| Total liabilities | $11.03 | $10.92 | $11.09 | $9.41 |
| Shareholders' equity | ||||
| Retained earnings | -$116.88 | -$95.89 | -$79.56 | -$63.88 |
| Other shareholder equity | -$1.46 | -$0.39 | $0 | $0.04 |
| Total shareholder equity | $301.98 | $321.08 | $336.24 | $350.71 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $110.54 | $60.63 | $2.06 | $3.32 |
| Short term investments | $143.22 | $124.06 | $0.01 | |
| Net receivables | $2.34 | $1.3 | ||
| Inventory | ||||
| Total current assets | $260.8 | $192.34 | $2.16 | $4.9 |
| Long term investments | $65.94 | $83.51 | $0.03 | |
| Property, plant & equipment | $5.22 | $3.58 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $71.21 | $87.23 | $0.03 | $0.04 |
| Total investments | $209.16 | $207.57 | $0.04 | |
| Total assets | $332.01 | $279.56 | $2.19 | $4.93 |
| Current liabilities | ||||
| Accounts payable | $0.57 | $1.16 | $0.42 | $0.12 |
| Deferred revenue | ||||
| Short long term debt | $0.29 | $0.12 | ||
| Total current liabilities | $9.29 | $4.41 | $1.27 | $0.57 |
| Long term debt | $1.63 | $0.88 | $1.55 | $0.7 |
| Total noncurrent liabilities | $1.63 | $0.88 | $3.59 | $2.2 |
| Total debt | $1.92 | $1 | $1.55 | |
| Total liabilities | $10.92 | $5.28 | $4.86 | $2.77 |
| Shareholders' equity | ||||
| Retained earnings | -$95.89 | -$41.04 | -$21.09 | -$15.93 |
| Other shareholder equity | -$0.39 | $0.03 | $17.05 | $17.05 |
| Total shareholder equity | $321.08 | $274.28 | -$19.72 | |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $14.46 | $12.62 | $10.71 | $12.02 |
| Selling, general & administrative | $8.93 | $6.16 | $7.12 | $4.61 |
| Total operating expenses | $23.39 | $18.78 | $17.83 | $16.64 |
| Operating income | -$23.39 | -$18.78 | -$17.83 | -$16.64 |
| Income from continuing operations | ||||
| EBIT | -$20.98 | -$16.34 | -$15.67 | -$13.97 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$20.98 | -$16.34 | -$15.67 | -$13.97 |
| Income (for common shares) | -$20.98 | -$16.34 | -$15.67 | -$13.97 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $42.79 | $13.29 | $3.79 | |
| Selling, general & administrative | $21.23 | $6.71 | $1.66 | |
| Total operating expenses | $64.02 | $20 | $5.45 | $5.01 |
| Operating income | -$64.02 | -$20 | -$5.45 | -$5.01 |
| Income from continuing operations | ||||
| EBIT | -$54.85 | -$19.95 | -$5.16 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$54.85 | -$19.95 | -$5.16 | -$5.1 |
| Income (for common shares) | -$54.85 | -$19.95 | -$5.16 | |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Net income | -$20.98 | -$16.34 | -$15.67 | -$13.97 |
| Operating activities | ||||
| Depreciation | $0.2 | $0.13 | $0.12 | $0.12 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.73 | $1.44 | $1.1 | $1.11 |
| Total cash flows from operations | -$16.57 | -$18.18 | -$10.3 | -$7.32 |
| Investing activities | ||||
| Capital expenditures | -$0.74 | -$1.03 | -$0.13 | -$0.11 |
| Investments | $24.59 | $22.4 | -$14.07 | $11.57 |
| Total cash flows from investing | $23.85 | $21.37 | -$14.2 | $11.46 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.21 | $0.01 | $0.13 | -$0.26 |
| Net borrowings | ||||
| Total cash flows from financing | $0.21 | $0.01 | $0.13 | -$0.26 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $7.48 | $3.21 | -$24.37 | $3.88 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Net income | -$54.85 | -$19.95 | -$5.16 | -$5.1 |
| Operating activities | ||||
| Depreciation | $0.48 | |||
| Business acquisitions & disposals | $0.04 | $0.01 | ||
| Stock-based compensation | $4.62 | $0.63 | $0.25 | |
| Total cash flows from operations | -$43.1 | -$24.11 | -$3.71 | -$4.48 |
| Investing activities | ||||
| Capital expenditures | -$1.57 | -$2.32 | ||
| Investments | -$2.51 | -$207.78 | $1.5 | |
| Total cash flows from investing | -$4.08 | -$210.07 | $1.51 | $2.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $97.09 | $209.16 | $0.07 | |
| Net borrowings | $1.66 | $0.87 | ||
| Total cash flows from financing | $97.09 | $292.75 | $0.95 | $1.46 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $49.91 | $58.57 | -$1.26 | -$1.01 |
News
Fundamentals
| Market cap | $121.14M |
|---|---|
| Enterprise value | $4.97M |
| Shares outstanding | 37.62M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$66.40M |
| EBIT | -$66.97M |
| Net Income | -$66.97M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -1.81 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -0.07 |
| EV/EBIT | -0.07 |
| P/S ratio | N/A |
| P/B ratio | 0.40 |
| Book/Share | 8.07 |
| Cash/Share | 3.14 |
| EPS | -$1.78 |
|---|---|
| ROA | -19.81% |
| ROE | -20.45% |
| Debt/Equity | 0.03 |
|---|---|
| Net debt/EBITDA | 1.61 |
| Current ratio | 28.42 |
| Quick ratio | 28.42 |